DrugPatentWatch Database Preview
Profile for Uruguay Patent: 35259
US Patent Family Members and Approved Drugs for Uruguay Patent: 35259
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Apr 10, 2031 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Try a Free Trial | Apr 10, 2031 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
➤ Try a Free Trial | Sep 10, 2029 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Try a Free Trial | Sep 10, 2029 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |